US Patent 12116371 Substituted pyridines as irreversible inhibitors of menin-MLL interaction
Patent 12116371 was granted and assigned to Biomea Fusion, Inc. on October, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12116371 Substituted pyridines as irreversible inhibitors of menin-MLL interaction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.